KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cognex (CGNX) EBT (2016 - 2025)

Cognex (CGNX) has disclosed EBT for 17 consecutive years, with $44.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 23.13% year-over-year to $44.1 million, compared with a TTM value of $182.8 million through Dec 2025, up 39.02%, and an annual FY2025 reading of $182.8 million, up 39.02% over the prior year.
  • EBT was $44.1 million for Q4 2025 at Cognex, down from $62.9 million in the prior quarter.
  • Across five years, EBT topped out at $93.5 million in Q3 2021 and bottomed at $14.4 million in Q4 2023.
  • Average EBT over 5 years is $51.0 million, with a median of $46.1 million recorded in 2025.
  • The sharpest move saw EBT skyrocketed 4145.76% in 2021, then plummeted 75.77% in 2023.
  • Year by year, EBT stood at $57.9 million in 2021, then increased by 2.22% to $59.2 million in 2022, then tumbled by 75.77% to $14.4 million in 2023, then soared by 149.41% to $35.8 million in 2024, then rose by 23.13% to $44.1 million in 2025.
  • Business Quant data shows EBT for CGNX at $44.1 million in Q4 2025, $62.9 million in Q3 2025, and $48.1 million in Q2 2025.